About Us
Arissa Medical Inc.
Syntra Origami Technology
Syntra Origami Technology
Arissa Medical is a privately owned medical device company based in Silicon Valley, CA, USA. We design and innovate Neurovascular products used by Interventional Neuroradiologists for the treatment of hemorrhagic stroke. Syntra intrasaccular device technology is currently a US FDA Breakthrough Designation application candidate under review for the treatment of Wide Neck Intracranial Aneurysms.
Syntra Origami Technology
Syntra Origami Technology
Syntra Origami Technology
Syntra is an intrasaccular Origami device for treating wide-neck and irregular intracranial aneurysms. Syntra implant delivered linearly as a 3D framing endo-bridge scaffold device that "unfolds" within the aneurysm sac in-situ. Syntra enables safe & effective treatment of acutely angulated wide neck sidewall & bifurcation aneurysms (ruptured/unruptured) without the need for DAPT.
FIH / Pilot Study
Syntra Origami Technology
FIH / Pilot Study
Successful First In Human (FIH) & Pilot Study at 6mo./12mo. DSA follow-up patient outcomes with no major adverse events.
Management
Byung Ju (BJ)
Byung Ju (BJ)
Byung Ju (BJ)
President / CEO
Seasoned technical executive/serial-entrepreneur with domestic/Int’l experience in R&D providing innovative medical device solutions in the areas of neurovascular, cardiovascular & peripheral vascular interventional minimally-invasive medical device technologies for over 36+ years.
Reza Sheikhai
Byung Ju (BJ)
Byung Ju (BJ)
CFO / BD
Veteran CPA with over 35+ years experience in finance & business development with midsize Fortune 500 Companies (IT/MedTech) with US & offshore presence.
Amiel Aguilar
Byung Ju (BJ)
Amiel Aguilar
Director of R&D
Medical device Research & Development professional with over 30+ years of technical and cross-functional management experience focused interventional minimally-invasive medical device product & technology development.
Advisory
